Quick Answer
HOOKIPA Pharma Inc. reported Stockholders Equity of $51.21 million for the year ending 2024.
- HOOKIPA Pharma Inc. showed a decrease of -43.0% in Stockholders Equity from 2023 to 2024.
- This data is from HOOKIPA Pharma Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$45.48 million | Q2 2018: -$54.12 million | Q3 2018: -$58.11 million | Q1 2019: -$70.06 million | Q2 2019: $136.03 million | Q3 2019: $125.76 million | Q1 2020: $108.98 million | Q2 2020: $103.92 million | Q3 2020: $92.18 million | Q1 2021: $140.06 million | Q2 2021: $125.93 million | Q3 2021: $108.09 million | Q1 2022: $147.93 million | Q2 2022: $131.95 million | Q3 2022: $113.35 million | Q1 2023: $83.48 million | Q2 2023: $112.33 million | Q3 2023: $95.05 million | Q4 2023: $89.86 million | Q1 2024: $104.52 million | Q2 2024: $86.06 million | Q3 2024: $71.80 million | Q4 2024: $51.21 million | Q1 2025: $34.08 million.
- Over the full 9 years of available data (2016 to 2024), HOOKIPA Pharma Inc.'s Stockholders Equity has grown by 257.7%.
- Historical annual values: Fiscal year 2024: $51.21 million | Fiscal year 2023: $89.86 million | Fiscal year 2022: $102.52 million | Fiscal year 2021: $89.59 million | Fiscal year 2020: $156.12 million | Fiscal year 2019: $117.90 million | Fiscal year 2018: -$60.38 million | Fiscal year 2017: -$42.66 million | Fiscal year 2016: -$32.47 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: